Does augmentation index reflect risk of coronary artery disease in elderly patients?
In elderly patients, AI may not be a useful marker to identify CAD.
According to our analysis of their contribution to prognostic factors, VEGF polymorphisms do not appear to exert a significant influence on RCC progression or prognosis. This finding might be explained by the tumor biology and pathogenesis of clear cell RCC. Additional studies with larger sample sizes are needed in different ethnic groups to further assess this association.